Skip to content

Remote Intervention to Prevent Overdose

A Remote Intervention to Prevent Overdose Among People Who Use Stimulants and/or Opioids

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07128485
Enrollment
100
Registered
2025-08-19
Start date
2027-01-01
Completion date
2027-11-01
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accidental Overdose of Opiate

Keywords

overdose prevention, fentanyl, opioid use disorder, stimulant use disorder, accidental overdose

Brief summary

This Type 1 hybrid effectiveness-implementation randomized controlled trial, A Remote Intervention to Prevent Overdose among People who Use Stimulants and/or Opioids, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of remote education on overdose outcomes, using a novel 2x2 design crossing remote education with remote access support. This research will inform scalability around remote education programs to address the nation's opioid overdose crisis.

Detailed description

This Type 1 hybrid effectiveness-implementation randomized controlled trial aims to address the United States overdose crisis driven by fentanyl and other synthetic opioids. Extant studies of overdose prevention programs are limited to single cities or regions and enroll from brick-and-mortar sites, with no national, fully remote RCTs to date, and it remains unknown whether education alone drives behavior change independent of access. This study will be the first national, fully remote trial to isolate the independent impact of remote education on overdose outcomes. This project adapts our opioid overdose education and naloxone distribution intervention using a human-centered design approach, leveraging community partnerships to co-create a fully remote intervention focused on overdose prevention strategies. Access to overdose prevention resources will be made available to participants independent of this award through referral to community partners. We will use a 2×2 design crossing remote education with remote access support, isolating the individual and combined effects of these two components. The R61 phase focuses on adapting and piloting the interventions with 100 participants, assessing feasibility, acceptability, and appropriateness. The R33 phase implements a fully powered trial to compare overdose outcomes (fatal and non-fatal) among 2,952 participants randomized to four arms: education plus access support, education only, access support only, and referral only (control). All groups will receive a resource list for overdose prevention tools. The secondary outcome is knowledge of how to use the resources correctly; exploratory outcomes include protective behavioral strategies to reduce overdose risk and utilization of substance use services and treatment. The study incorporates ecological momentary assessment to elucidate daily contextual factors influencing resource use, and a cost-effectiveness analysis to identify the most cost efficient approach. Findings will directly inform scalable, low-barrier models capable of reaching rural and underserved populations not currently engaged in substance use services.

Interventions

OTHEROverdose prevention resources

Overdose prevention resources (e.g., naloxone) are resources used to prevent drug overdose.

BEHAVIORALOverdose prevention education

Developed in the R61 phase, the educational intervention will provide participants with knowledge about how prevent drug overdose.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Using a 2x2 design, there will be four study arms. All arms will receive a resource list for obtaining overdose prevention resources such as naloxone on their own, while while other arms will additionally receive overdose prevention education, access to overdose prevention resources, or both. These 4 groups include: education plus access support, education only, access support only, and referral only (control).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years old * English-speaking and reading * Report using illicit opioids and/or stimulants (including counterfeit pills) within the past 3 months per the ASSIST * Able and willing to provide informed consent * Be able and willing to provide the names and contact information of three close contacts to reach if the participant cannot be reached

Exclusion criteria

* Living in a restricted environment (e.g., prison)

Design outcomes

Primary

MeasureTime frameDescription
OverdoseBaseline, 1 month, 3 months, 6 monthsIncludes both self-reported non-fatal overdose and fatal overdose

Secondary

MeasureTime frameDescription
Overdose prevention knowledgeBaseline, 1 month, 3 months, 6 monthsSelf-reported knowledge of how and when to use overdose prevention tools correctly, based on the education intervention developed in R61 phase

Countries

United States

Contacts

CONTACTEmma S Kay, PhD, MSW
emmakay@uab.edu205-996-5547

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026